Home Newsletters Immune Regulation News Systemic Inhibition of PTPN22 Augments Anticancer Immunity

Systemic Inhibition of PTPN22 Augments Anticancer Immunity

By

-

July 21, 2021

In mice, lack of PTPN22 augmented antitumor activity with greater infiltration and activation of macrophages, natural killer (NK) cells, and T cells.

[Journal of Clinical Investigation]

Sorry, but the selected Zotpress account can't be found.

Abstract Graphical Abstract

Exit mobile version